Song B
Int J Mol Sci. 2025; 26(5).
PMID: 40076976
PMC: 11900391.
DOI: 10.3390/ijms26052357.
Hu L, Han J, Wang H, Cheng Z, Lv C, Liu D
Nat Commun. 2025; 16(1):1260.
PMID: 39893181
PMC: 11787337.
DOI: 10.1038/s41467-025-56655-7.
Yang X, Zhu P, Gui J
Int J Mol Sci. 2024; 25(15).
PMID: 39125884
PMC: 11313136.
DOI: 10.3390/ijms25158314.
Li T, Li S, Kang Y, Zhou J, Yi M
J Transl Med. 2024; 22(1):749.
PMID: 39118151
PMC: 11312220.
DOI: 10.1186/s12967-024-05570-4.
Hao W, Cui W, Liu Z, Suo F, Wu Y, Han L
Adv Sci (Weinh). 2024; 11(22):e2309767.
PMID: 38602436
PMC: 11165516.
DOI: 10.1002/advs.202309767.
Domain-inlaid Nme2Cas9 adenine base editors with improved activity and targeting scope.
Bamidele N, Zhang H, Dong X, Cheng H, Gaston N, Feinzig H
Nat Commun. 2024; 15(1):1458.
PMID: 38368418
PMC: 10874451.
DOI: 10.1038/s41467-024-45763-5.
CRISPR technologies for genome, epigenome and transcriptome editing.
Villiger L, Joung J, Koblan L, Weissman J, Abudayyeh O, Gootenberg J
Nat Rev Mol Cell Biol. 2024; 25(6):464-487.
PMID: 38308006
DOI: 10.1038/s41580-023-00697-6.
Protein Engineering Technologies for Development of Next-Generation Genome Editors.
Winter J, Shirguppe S, Perez-Pinera P
Curr Opin Biomed Eng. 2023; 28.
PMID: 38095011
PMC: 10715798.
DOI: 10.1016/j.cobme.2023.100514.
Rapid characterization of anti-CRISPR proteins and optogenetically engineered variants using a versatile plasmid interference system.
Song G, Tian C, Li J, Zhang F, Peng Y, Gao X
Nucleic Acids Res. 2023; 51(22):12381-12396.
PMID: 37930830
PMC: 10711425.
DOI: 10.1093/nar/gkad995.
Split complementation of base editors reduces off-target edits.
Nat Plants. 2023; 9(11):1787-1788.
PMID: 37864048
DOI: 10.1038/s41477-023-01548-0.
Split complementation of base editors to minimize off-target edits.
Xiong X, Liu K, Li Z, Xia F, Ruan X, He X
Nat Plants. 2023; 9(11):1832-1847.
PMID: 37845337
DOI: 10.1038/s41477-023-01540-8.
Precise genome editing with base editors.
Liu H, Zhu Y, Li M, Gu Z
Med Rev (2021). 2023; 3(1):75-84.
PMID: 37724105
PMC: 10471085.
DOI: 10.1515/mr-2022-0044.
Recent advances in therapeutic CRISPR-Cas9 genome editing: mechanisms and applications.
Zhou L, Yao S
Mol Biomed. 2023; 4(1):10.
PMID: 37027099
PMC: 10080534.
DOI: 10.1186/s43556-023-00115-5.
Engineered CRISPR prime editors with compact, untethered reverse transcriptases.
Grunewald J, Miller B, Szalay R, Cabeceiras P, Woodilla C, Holtz E
Nat Biotechnol. 2022; 41(3):337-343.
PMID: 36163548
PMC: 10023297.
DOI: 10.1038/s41587-022-01473-1.
Cytosine base editing systems with minimized off-target effect and molecular size.
Li A, Mitsunobu H, Yoshioka S, Suzuki T, Kondo A, Nishida K
Nat Commun. 2022; 13(1):4531.
PMID: 35941130
PMC: 9359979.
DOI: 10.1038/s41467-022-32157-8.
Internally inlaid SaCas9 base editors enable window specific base editing.
Jiang L, Long J, Yang Y, Zhou L, Su J, Qin F
Theranostics. 2022; 12(10):4767-4778.
PMID: 35832085
PMC: 9254239.
DOI: 10.7150/thno.70869.
Adenine Base Editing with a Single Adeno-Associated Virus Vector.
Zhang H, Bamidele N, Liu P, Ojelabi O, Gao X, Rodriguez T
GEN Biotechnol. 2022; 1(3):285-299.
PMID: 35811581
PMC: 9258002.
DOI: 10.1089/genbio.2022.0015.
HDAC inhibitors improve CRISPR-Cas9 mediated prime editing and base editing.
Liu N, Zhou L, Lin G, Hu Y, Jiao Y, Wang Y
Mol Ther Nucleic Acids. 2022; 29:36-46.
PMID: 35784015
PMC: 9207553.
DOI: 10.1016/j.omtn.2022.05.036.
Engineering of near-PAMless adenine base editor with enhanced editing activity and reduced off-target.
Cao X, Guo J, Huang S, Yu W, Li G, An L
Mol Ther Nucleic Acids. 2022; 28:732-742.
PMID: 35664696
PMC: 9126838.
DOI: 10.1016/j.omtn.2022.04.032.
dCas9 binding inhibits the initiation of base excision repair in vitro.
Antony J, Roberts S, Wyrick J, Hinz J
DNA Repair (Amst). 2021; 109:103257.
PMID: 34847381
PMC: 8748382.
DOI: 10.1016/j.dnarep.2021.103257.
